Summary Of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2020

Summary Of Significant Accounting Policies [Abstract]

Summary Of Net Revenue Disaggregated By Product And Region

	Three Months Ended ‎December 31,				Six Months Ended ‎December 31,
	2020		2019		2020		2019
U.S., Canada and Latin America
Devices	$	204,997	$	203,522	$	402,390	$	390,409
Masks and other		221,764		204,444		427,524		387,805
Total Sleep and Respiratory Care	$	426,761	$	407,966	$	829,914	$	778,214
Software as a Service		91,833		86,706		183,976		173,596
Total	$	518,594	$	494,672	$	1,013,890	$	951,810
Combined Europe, Asia and other markets
Devices	$	187,992	$	162,311	$	364,018	$	314,236
Masks and other		93,425		79,174		174,047		151,167
Total Sleep and Respiratory Care	$	281,417	$	241,485	$	538,065	$	465,403
Global revenue
Devices	$	392,989	$	365,833	$	766,408	$	704,645
Masks and other		315,189		283,618		601,571		538,972
Total Sleep and Respiratory Care	$	708,178	$	649,451	$	1,367,979	$	1,243,617
Software as a Service		91,833		86,706		183,976		173,596
Total	$	800,011	$	736,157	$	1,551,955	$	1,417,213

Summary Of Contract Balances

	December 31, ‎2020		June 30, ‎2020		Balance sheet caption
Contract assets
Accounts receivable, net	$	509,364	$	474,643	Accounts receivable, net
Unbilled revenue, current		9,453		9,452	Prepaid expenses and other current assets
Unbilled revenue, non-current		5,885		6,957	Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current		(105,238)		(98,617)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(86,899)		(87,307)	Deferred revenue (non-current liabilities)

Schedule Of Components Of Lease Revenue

	Three Months Ended ‎December 31,				Six Months Ended ‎December 31,
	2020		2019		2020		2019
Sales-type lease revenue	$	1,863	$	3,068	$	3,823	$	5,326
Operating lease revenue		25,026		21,317		49,805		42,952
Total lease revenue	$	26,889	$	24,385	$	53,628	$	48,278